1 |
Sukor N. Endocrine hypertension: current understanding and comprehensive management review. Eur J Intern Med 2011;22:433-440.
DOI
ScienceOn
|
2 |
Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996;275:1571-1576.
DOI
ScienceOn
|
3 |
Baruah MP, Kalra S, Unnikrishnan AG. Endocrine hypertension: changing paradigm in the new millennium. Indian J Endocrinol Metab 2011;15(Suppl 4):S275-S278.
DOI
|
4 |
Faselis C, Doumas M, Papademetriou V. Common secondary causes of resistant hypertension and rational for treatment. Int J Hypertens 2011;2011:236-239.
|
5 |
Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006;48:2293-2300.
DOI
ScienceOn
|
6 |
Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004;89:1045-1050.
DOI
ScienceOn
|
7 |
Beard CM, Sheps SG, Kurland LT, Carney JA, Lie JT. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1983;58:802-804.
|
8 |
Stewart BH, Bravo EL, Meaney TF. A new simplified approach to the diagnosis of pheochromocytoma. J Urol 1979;122:579-581.
DOI
|
9 |
Sukor N. Secondary hypertension: a condition not to be missed. Postgrad Med J 2011;87:706-713.
DOI
ScienceOn
|
10 |
Schwartz GL. Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness. Endocrinol Metab Clin North Am 2011;40:279-294.
DOI
ScienceOn
|
11 |
Young WF Jr. Endocrine hypertension: then and now. Endocr Pract 2010;16:888-902.
DOI
ScienceOn
|
12 |
Anagnostis P, Karagiannis A, Tziomalos K, Athyros VG, Kita M, Mikhailidis DP. Endocrine hypertension: diagnosis and management of a complex clinical entity. Curr Vasc Pharmacol 2010;8:646-660.
DOI
ScienceOn
|
13 |
Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams Textbook of Endocrinology. 12th ed. Philadelphia: Elsevier/Saunders, 2011.
|
14 |
Nimkarn S, New MI. Steroid 11beta-hydroxylase deficiency congenital adrenal hyperplasia. Trends Endocrinol Metab 2008;19:96-99.
DOI
ScienceOn
|
15 |
Wang W, Fu JF, Gong FQ, Zhu WH, Shen Z. Rare hypertension as a result of 17alpha-hydroxylase deficiency. J Pediatr Endocrinol Metab 2011;24:333-337.
|
16 |
Scacchi M, Cavagnini F. Acromegaly. Pituitary 2006;9:297-303.
DOI
ScienceOn
|